We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.41%
AUM
$13.9B
AUM Growth
-$141M
Cap. Flow
-$425M
Cap. Flow %
-3.07%
Top 10 Hldgs %
34.53%
Holding
3,023
New
28
Increased
1,092
Reduced
1,855
Closed
41

Top Buys

Rank Stock Value
1
CRH icon
CRH
CRH
+$11M
2
CVNA icon
Carvana
CVNA
+$7.62M
3
PINS icon
Pinterest
PINS
+$7.21M
4
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$5.17M
5
ARES icon
Ares Management
ARES
+$4.45M

Sector Composition

Rank Sector Weight
1 Technology 33.29%
2 Financials 13.13%
3 Consumer Discretionary 11.05%
4 Communication Services 9.85%
5 Healthcare 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUN icon
1701
Huntsman Corp
HUN
$1.79B
$100K ﹤0.01%
10,002
+1,471
+17% +$13.5K
TVTX icon
1702
Travere Therapeutics
TVTX
$5.8B
$99K ﹤0.01%
2,592
-308
-11% -$10K
WSBC icon
1703
WesBanco
WSBC
$4.05B
$99K ﹤0.01%
2,976
+17
+0.6% +$550
GSAT icon
1704
Globalstar
GSAT
$10.8B
$96K ﹤0.01%
1,576
-126
-7% -$6.96K
GRAL
1705
GRAIL Inc
GRAL
$3.1B
$95K ﹤0.01%
1,105
+163
+17% +$14.1K
TPC
1706
Tutor Perini Cor
TPC
$5.09B
$94K ﹤0.01%
1,400
-99
-7% -$6.49K
HURN icon
1707
Huron Consulting
HURN
$2.39B
$93K ﹤0.01%
536
-65
-11% -$10.6K
REVG
1708
DELISTED
REV Group
REVG
$93K ﹤0.01%
1,525
-48
-3% -$2.69K
BRZE icon
1709
Braze
BRZE
$3.12B
$92K ﹤0.01%
2,682
+421
+19% +$12.5K
AMBA icon
1710
Ambarella
AMBA
$3.67B
$91K ﹤0.01%
1,280
-50
-4% -$4.04K
APGE icon
1711
Apogee Therapeutics
APGE
$10.2B
$91K ﹤0.01%
1,210
+149
+14% +$9.38K
TENB icon
1712
Tenable Holdings
TENB
$4.05B
$90K ﹤0.01%
3,817
-285
-7% -$7.79K
GLIBK
1713
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.02B
$90K ﹤0.01%
2,411
+1,063
+79% +$37.3K
NG icon
1714
NovaGold Resources
NG
$3.5B
$89K ﹤0.01%
9,523
+1,338
+16% +$12.4K
OSCR icon
1715
Oscar Health
OSCR
$9.06B
$89K ﹤0.01%
6,214
-37
-0.6% -$640
BLSH
1716
Bullish
BLSH
$3.76B
$89K ﹤0.01%
+2,341
New +$114K
VERA icon
1717
Vera Therapeutics
VERA
$2.17B
$88K ﹤0.01%
1,746
+211
+14% +$7.49K
GTX icon
1718
Garrett Motion
GTX
$5.45B
$87K ﹤0.01%
4,994
+657
+15% +$10.5K
IDYA icon
1719
IDEAYA Biosciences
IDYA
$3.54B
$87K ﹤0.01%
2,523
-79
-3% -$2.52K
LBTYK icon
1720
Liberty Global Class C
LBTYK
$3.45B
$86K ﹤0.01%
7,795
+841
+12% +$9.35K
CRSR icon
1721
Corsair Gaming
CRSR
$1.41B
$85K ﹤0.01%
14,340
+963
+7% +$6.7K
DBRG icon
1722
DigitalBridge
DBRG
$2.95B
$85K ﹤0.01%
5,569
-50
-0.9% -$601
BEAM icon
1723
Beam Therapeutics
BEAM
$2.77B
$83K ﹤0.01%
3,004
-149
-5% -$3.8K
SPHR icon
1724
Sphere Entertainment
SPHR
$6.21B
$83K ﹤0.01%
874
-33
-4% -$2.52K
CLVT icon
1725
Clarivate
CLVT
$1.2B
$82K ﹤0.01%
24,673
+7,205
+41% +$25.6K

Similar funds

Amalgamated Bank's Q4 2025 Portfolio in Review

As of Q4 2025, Amalgamated Bank held 3,023 positions worth $13.9B, down 1% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Amalgamated Bank withdrew a net $425M in Q4 2025, closing 41 positions and reducing 1,855 holdings. Its most notable exit was Kellanova, an estimated $4.43M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Amalgamated Bank opened a new position in Qnity Electronics Inc worth $3.35M.

  • Amalgamated Bank's largest Q4 2025 buy was Qnity Electronics Inc: 40,967 shares worth $3.35M.
  • Amalgamated Bank added most to CRH in Q4 2025, an estimated $11M increase.
  • Amalgamated Bank's biggest Q4 2025 reduction was Apple, cutting an estimated $53M.
  • Amalgamated Bank fully exited Kellanova in Q4 2025, selling an estimated $4.43M.
  • Amalgamated Bank's ten largest holdings make up 35% of its $13.9B portfolio in Q4 2025.
  • Amalgamated Bank opened 28 new positions and closed 41 in Q4 2025.
  • Amalgamated Bank's portfolio value fell 1% quarter-over-quarter to $13.9B.

Based on Amalgamated Bank's 13F filing for Q4 2025, filed 5 Feb 2026.